Form 8-K - Current report:
SEC Accession No. 0001493152-22-014094
Filing Date
2022-05-17
Accepted
2022-05-17 08:01:18
Documents
15
Period of Report
2022-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39380
2 ex99-1.htm EX-99.1 31051
3 ex99-1_01.jpg GRAPHIC 18400
4 ex99-1_02.jpg GRAPHIC 15138
  Complete submission text file 0001493152-22-014094.txt   301518

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20220516.xsd EX-101.SCH 3063
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20220516_lab.xml EX-101.LAB 34476
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20220516_pre.xml EX-101.PRE 22615
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3611
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 22932290
SIC: 2834 Pharmaceutical Preparations